Updated clinical data demonstrates a prolonged and sustained favorable safety profile for roginolisib (IOA-244) Clinical data shows a comparable safety profile in both solid and hematologic malignancies Clinical responses seen in both solid and hematologic malignancies US FDA grants Orphan Drug Designation for IOA-244 in uveal melanoma Geneva, Switzerland and Amsterdam, The Netherlands, 5 January – iOnctura, a […]